University of Münster
CRIS@UM
DE | EN

Dr. Jörg Fabian

Current affiliations

  • Institute for Pharmaceutical and Medical Chemistry
Logo ORCIDID
0000-0001-9673-5527

Publications

Development and validation of a bioanalytical method for the quantification of methotrexate from serum and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS.
Opitz P, Fobker M, Fabian J, Hempel G (2024)
In: Journal of Chromatographic Science, 1715, 464610. doi:10.1016/j.chroma.2023.464610
Research article (journal) | Peer reviewed | Published
Investigations on the metabolic stability of cytosolic phospholipase A 2α inhibitors with 1-indolylpropan-2-one structure
Fabian J., Hanekamp W., Thomas M.H., Olivier J.L., Lehr M. (2013)
In: Chemico-Biological Interactions, 206(2), 356-363. doi:10.1016/j.cbi.2013.10.005
Research article (journal) | Peer reviewed | Published
Pyrrole alkanoic acid derivatives as nuisance inhibitors of microsomal prostaglandin E 2 synthase-1
Wiegard A., Hanekamp W., Griessbach K., Fabian J., Lehr M. (2012)
In: European Journal of Medicinal Chemistry, 48(null), 153-163. doi:10.1016/j.ejmech.2011.12.009
Research article (journal) | Peer reviewed | Published
Enantiomerically pure 1,3-dioxanes as highly selective NMDA and σ1 receptor ligands
Köhler J., Bergander K., Fabian J., Schepmann D., Wünsch B. (2012)
In: Journal of Medicinal Chemistry, 55(20), 8953-8957. doi:10.1021/jm301166m
Research article (journal) | Peer reviewed | Published
1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A(2)alpha with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity.
Drews A, Bovens S, Roebrock K, Sunderkötter C, Reinhardt D, Schäfers M, van der Velde A, Schulze Elfringhoff A, Fabian J, Lehr M (2010)
In: Journal of Medicinal Chemistry, 53(14), 5165-5178. doi:10.1021/jm1001088
Research article (journal) | Peer reviewed | Published
Show all publications